1. Home
  2. MNKD vs PRCH Comparison

MNKD vs PRCH Comparison

Compare MNKD & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • PRCH
  • Stock Information
  • Founded
  • MNKD 1991
  • PRCH 2012
  • Country
  • MNKD United States
  • PRCH United States
  • Employees
  • MNKD N/A
  • PRCH N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • PRCH Computer Software: Prepackaged Software
  • Sector
  • MNKD Health Care
  • PRCH Technology
  • Exchange
  • MNKD Nasdaq
  • PRCH Nasdaq
  • Market Cap
  • MNKD 1.2B
  • PRCH 1.3B
  • IPO Year
  • MNKD 2004
  • PRCH N/A
  • Fundamental
  • Price
  • MNKD $3.73
  • PRCH $15.34
  • Analyst Decision
  • MNKD Buy
  • PRCH Strong Buy
  • Analyst Count
  • MNKD 6
  • PRCH 7
  • Target Price
  • MNKD $9.17
  • PRCH $13.71
  • AVG Volume (30 Days)
  • MNKD 3.1M
  • PRCH 2.0M
  • Earning Date
  • MNKD 08-06-2025
  • PRCH 08-05-2025
  • Dividend Yield
  • MNKD N/A
  • PRCH N/A
  • EPS Growth
  • MNKD 149.32
  • PRCH N/A
  • EPS
  • MNKD 0.11
  • PRCH 0.52
  • Revenue
  • MNKD $301,736,000.00
  • PRCH $435,601,000.00
  • Revenue This Year
  • MNKD $13.62
  • PRCH N/A
  • Revenue Next Year
  • MNKD $15.18
  • PRCH $14.98
  • P/E Ratio
  • MNKD $34.33
  • PRCH $29.34
  • Revenue Growth
  • MNKD 21.48
  • PRCH N/A
  • 52 Week Low
  • MNKD $3.38
  • PRCH $1.16
  • 52 Week High
  • MNKD $7.63
  • PRCH $17.38
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 48.69
  • PRCH 60.73
  • Support Level
  • MNKD $3.60
  • PRCH $14.13
  • Resistance Level
  • MNKD $3.81
  • PRCH $16.26
  • Average True Range (ATR)
  • MNKD 0.17
  • PRCH 0.96
  • MACD
  • MNKD -0.00
  • PRCH 0.14
  • Stochastic Oscillator
  • MNKD 50.72
  • PRCH 63.04

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

Share on Social Networks: